IFNG and neoplasm: The correlation between IDO1 and CXCL9 (as an IFN-γ responsive marker) has been assessed in colorectal carcinomas, melanomas, and other cancer types (10), but the correlation between IDO and IL-10RA in real tumours remains poorly elucidated.